Surprising reactions of iodo Pt(IV) and Pt(II) complexes with human albumin: Detection of Cys34 sulfenic acid

Journal of the American Chemical Society

Volumn 121, Issue 36, 1999, Pages 8193-8203

  Kratochwil, Nicole A ^a   Ivanov, Andrei I ^a   Patriarca, Marina ^a   Parkinson, John A ^a   Gouldsworthy, Adam M ^a   Murdoch, Piedad Del Socorro ^a   Sadler, Peter J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; CISPLATIN; IODIDE; LIGAND; PLATINUM COMPLEX; PLATINUM DERIVATIVE; SULFENIC ACID DERIVATIVE; THIOL DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG DESIGN; DRUG PROTEIN BINDING; HUMAN; REACTION ANALYSIS; STEREOISOMERISM;

EID: 0033568052     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja990768n     Document Type: Article

References (96)

1. Beale, P. J.; Kelland, L. R.; Judson, I. R. Expert Opin. Invest. Drugs 1996, 5, 681-693.
2. Holford, J.; Sharp, S. Y.; Murrer, B. A.; Abrams, M.; Kelland, L. R. Br. J. Cancer 1998, 77, 366-373.
3. Pratesi, G.; Giuliani, F. C.; Polizzi, D.; Righetti, S.; Manzotti, C.; Pezzoni, G.; Farrell, N.; Zunino, F. Proc. Annu. Meet. Am. Assoc. Cancer Res. 1997, 38, 310.
4. (a) Poon, G. K.; Raynaud, F. I.; Mistry, P.; Odell, D. E.; Kelland, L. R.; Harrap, K. R.; Barnard, C. F. J.; Murrer, B. A. J. Chromatogr. A 1995, 712, 61-66.
5. (b) Raynaud, F. I.; Mistry, P.; Donaghue, A.; Poon, G. K.; Kelland, L. R.; Barnard, C. F. J.; Murrer, B. A.; Harrap, K. R. Cancer Chemother. Pharmacol. 1996, 38, 155-162.
6. (a) Cleare, M. J.; Hoeschele, J. D. Bioinorg. Chem. 1973, 2, 187-210.
7. (b) Hydes, P. H.; Russell, M. J. H. Cancer Metastasis Rev. 1988, 7, 67-89.
8. (a) Dhara, S. C. Ind. J. Chem. 1970, 8, 193-194.
9. (b) Hegmans, A.; Sabat, M.; Baxter, I.; Freisinger, E.; Lippert, B. Inorg. Chem. 1998, 37, 4921-4928.
10. (a) Rochon, F. D.; Kong, P. C. Can. J. Chem. 1986, 64, 1894-1896.
11. (b) Talman, E. G.; Brüning, W.; Reedijk, J.; Spek, A. L.; Veldman, N. Inorg. Chem. 1997, 36, 854-861.
12. O'Halloran, T. V.; Lippard, S. J.; Richmond, T. J.; Klug, A. J. Mol. Biol. 1987, 194, 705-712.
13. (a) Basolo, F.; Gray, H. B.; Pearson, R. G. J. Am. Chem. Soc. 1960, 82, 4200-4203.
14. (b) Thiele, G.; Wagner, D. Chem. Ber. 1978, 111, 3162-3170.
15. (c) Annibale, G.; Canovese, L.; Cattalini, L.; Marangoni, G.; Michelon, G.; Tobe, M. L. Inorg. Chem. 1981, 20, 2428-2431.
16. (d) Kerrison, S. J. S.; Sadler, P. J. Inorg. Chim. Acta 1985, 104, 197-201.
17. (e) Ha, T. T. B.; Wimmer, F. L.; Souchard, J.-P.; Johnson, N. P.; Jaud, J. J. Chem. Soc., Dalton Trans. 1990, 1251-1255.
18. (f) Qu, Y.; Gama del Almeida, S.; Farrell, N. Inorg. Chim. Acta 1992, 201, 123-129.
19. (g) Qu, Y.; Farrell, N.; Valsecchi, M.; de Greco, L.; Spinelli, S. Magn. Res. Chem. 1993, 31, 920-924.
20. (a) Burgeson, I. E.; Kostic, N. M. Inorg. Chem. 1991, 30, 4299-4305.
21. (b) Bose, R. N.; Moghaddas, S.; Weaver, E. L.; Cox, E. H. Inorg. Chem. 1995, 34, 5878-5883.
22. (c) Whittaker, J.; McFadyen, W. D.; Wickham, G.; Wakelin, L. P. G.; Murray, V. Nucleic Acids Res. 1998, 26, 3933-3939.
23. (a) Kratochwil, N. A.; Zabel, M.; Range, K. J.; Bednarski, P. J. J. Med. Chem. 1996, 39, 2499-2507.
24. (b) Kratochwil, N. A.; Parkinson, J. A.; Bednarski, P. J.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 1460-1463.
25. (a) Bose, R. N.; Weaver, E. L. J. Chem. Soc., Dalton Trans. 1997, 1797-1799.
26. (b) Chaney, S. G. Int. J. Oncol. 1995, 6, 1291-1305
27. (c) Pendyala, L.; Creaven, P. J.; Perez, R.; Zdanowicz, J. R.; Raghavan, D. Cancer Chemother. Pharmacol. 1995, 36, 271-278.
28. (d) Kido, Y. C.; Khokhar, A. R.; Siddik, Z. H. Biochem. Pharmacol. 1994, 47, 1635-1642.
29. (e) Gibbons, G. R.; Wyrick, S.; Chaney, S. G. Cancer Res. 1989, 49, 1402-1407.
30. (f) Eastman, A. Biochem. Pharmacol. 1987, 36, 4177-4178.
31. (g) Blatter, E. E.; Vollano, J. F.; Krishnnan, B. S.; Dabrowiak, J. C. Biochemistry 1984, 23, 4817-4820.
32. Attack on a coordinated ligand with labilization of the trans ligand is a well-established mechanism for reduction of Pt(IV) complexes, but the mechansims for thiol attack are poorly understood, see Shi, T. S.; Berglund, J.; Elding, L. I. Inorg. Chem. 1996, 35, 3498-3503 and references therein.
33. Kratochwil, N. A.; Guo, Z.; Murdoch, P. del Socorro; Parkinson, J. A.; Bednarski, P. J.; Sadler, P. J. J. Am. Chem. Soc. 1998, 120, 8253-8254.
34. (a) Carter, D. C.; Ho, J. X. Adv. Protein Chem. 1994, 45, 153-203.
35. (b) Peters, T., Jr. All about albumin. Biochemistry, genetics, and medical applications; Academic Press: San Diego, CA, 1996.
36. (c) He, X. M.; Carter, D. C Nature 1992, 358, 209-215.
37. DeMaster, E. G.; Quast, B. J.; Redfern, B.; Nagasawa, H. T. Biochemistry 1995, 34, 11494-11499.
38. Radi, R.; Beckman, J. S.; Bush, K. M.; Freeman, B. A. J. Biol. Chem. 1991, 266, 4244-4250.
39. Jirousek, L.; Pritchard, E. T. Biochim. Biophys. Acta 1971, 229, 618-630.
40. Ivanov, A. I.; Christodoulou, J.; Parkinson, J. A.; Bamham, K. J.; Tucker, A.; Woodrow, J.; Sadler, P. J. J. Biol. Chem. 1998, 273, 14721-14730.
41. Torchinsky, Y. M. Sulfur in proteins; Pergamon Press: Oxford, U.K., 1981.
42. (a) Denu, J. M.; Tanner, K. G. Biochemistry 1998, 37, 5633-5642.
43. (b) Ellis, H. R.; Poole, L. B. Biochemistry 1997, '36, 15013-15018.
44. Patriarca, M.; Kratochwil, N. A.; Sadler, P. J. J. Anal. At. Spectrom. 1999, 14, 633-637.
45. Differences between isolated albumin and the albumin in blood plasma are discussed in: Christodoulou, J.; Sadler, P. J.; Tucker, A. FEBS Lett. 1995, 376, 1-5.
46. (a) Miki, M. J. Biochem. 1985, 97, 1067-1072.
47. (b) Aboderin, A. A.; Boedefeld, E.; Luisi, P. L. Biochim. Biophys. Acta 1973, 328, 20-30.
48. (a) Choi, S.; Filotto, C.; Bisanzo, M.; Delaney, S.; Lagasee, D.; Whitworth, J. L.; Jusko, A.; Li, C. R.; Wood, N. A.; Willingham, J.; Schwenker, A.; Spaulding, K. Inorg. Chem. 1998, 37, 2500-2504.
49. (b) Ellis, L. T.; Er, H. M.; Hambley, T. W. Aust. J. Chem. 1995, 48, 793-806.
50. (c) Yoshida, M.; Khokhar, A. R.; Siddik, Z. H. Cancer Res. 1994, 54, 4691-4697.
51. (d) Kido, Y.; Khokhar, A. R.; Al-Baker, S.; Siddik, Z. H. Cancer Res. 1993, 53, 4567-4572.
52. (a) Kukushkin, Y. N.; Vshivtsev, V. I.; Spevak, V. N. Zh. Neorg. Khim. 1975, 20, 3123-3125.
53. (c) Zheligovskaya, N. N.; Khidzhazi, R.; Spitsyn, V.; Van'ko, S. I. Izv. Akad. Nauk SSSR, Ser. Khim. 1973, 1, 160-162.
54. (a) Peloso, A.; Dolcetti, G.; Ettorre, R. Inorg. Chim. Acta 1967, 1, 403-406.
55. (b) Peloso, A. Coord. Chem. Rev. 1973, 123-181.
56. Peloso, A. Polyhedron 1992, 11, 2187-2193.
57. Pedersen, A. O.; Jacobsen, J. J. Eur. J. Biochem. 1980, 106, 291-295.
58. Lewis, S. D.; Shafer, J. A. Biochemistry 1980, 19, 6129-6137.
59. Whitesides, G. M.; Lilburn, J. E.; Szahewski, R. P. J. Org. Chem. 1977, 42, 332-338.
60. 5+ has been characterized by X-ray analysis, can be viewed as containing a derivative of a coordinated sulfenyl iodide, and reacts with thiols to form disulfides: Nosco, D. L.; Heeg, M. J.; Glick, M. D.; Elder, R. C.; Deutsch, E. J. Am. Chem. Soc. 1980, 102, 7786-7787. (d) Ishii, A.; Komiya, K.; Nakayama, J. J. Am. Chem. Soc. 1996, 118, 12836-12837 and references therein, (e) Goto, K.; Holler, M.; Okazaki, R. J. Am. Chem. Soc. 1997, 119, 1460-1461 and references therein.
61. 5+ has been characterized by X-ray analysis, can be viewed as containing a derivative of a coordinated sulfenyl iodide, and reacts with thiols to form disulfides: Nosco, D. L.; Heeg, M. J.; Glick, M. D.; Elder, R. C.; Deutsch, E. J. Am. Chem. Soc. 1980, 102, 7786-7787. (d) Ishii, A.; Komiya, K.; Nakayama, J. J. Am. Chem. Soc. 1996, 118, 12836-12837 and references therein, (e) Goto, K.; Holler, M.; Okazaki, R. J. Am. Chem. Soc. 1997, 119, 1460-1461 and references therein.
62. 5+ has been characterized by X-ray analysis, can be viewed as containing a derivative of a coordinated sulfenyl iodide, and reacts with thiols to form disulfides: Nosco, D. L.; Heeg, M. J.; Glick, M. D.; Elder, R. C.; Deutsch, E. J. Am. Chem. Soc. 1980, 102, 7786-7787. (d) Ishii, A.; Komiya, K.; Nakayama, J. J. Am. Chem. Soc. 1996, 118, 12836-12837 and references therein, (e) Goto, K.; Holler, M.; Okazaki, R. J. Am. Chem. Soc. 1997, 119, 1460-1461 and references therein.
63. 5+ has been characterized by X-ray analysis, can be viewed as containing a derivative of a coordinated sulfenyl iodide, and reacts with thiols to form disulfides: Nosco, D. L.; Heeg, M. J.; Glick, M. D.; Elder, R. C.; Deutsch, E. J. Am. Chem. Soc. 1980, 102, 7786-7787. (d) Ishii, A.; Komiya, K.; Nakayama, J. J. Am. Chem. Soc. 1996, 118, 12836-12837 and references therein, (e) Goto, K.; Holler, M.; Okazaki, R. J. Am. Chem. Soc. 1997, 119, 1460-1461 and references therein.
64. 5+ has been characterized by X-ray analysis, can be viewed as containing a derivative of a coordinated sulfenyl iodide, and reacts with thiols to form disulfides: Nosco, D. L.; Heeg, M. J.; Glick, M. D.; Elder, R. C.; Deutsch, E. J. Am. Chem. Soc. 1980, 102, 7786-7787. (d) Ishii, A.; Komiya, K.; Nakayama, J. J. Am. Chem. Soc. 1996, 118, 12836-12837 and references therein, (e) Goto, K.; Holler, M.; Okazaki, R. J. Am. Chem. Soc. 1997, 119, 1460-1461 and references therein.
65. (a) Trundle, D.; Cunningham, L. W. Biochemistry 1969, 8, 1919-1925.
66. (b) Parker, D. J.; Allison, W. S. J. Biol. Chem. 1969, 244, 180-189.
67. (a) Raynaud, F. I.; Boxall, F. E.; Goddard, P.; Barnard, C.; Murrer, B. A.; Kelland, L. R. Anticancer Res. 1996, 16, 1857-1862.
68. (b) van der Vijgh, W. J. F.; Klein, I. Cancer Chemother. Pharmacol. 1986, 18, 129-132.
69. (a) Poon, G. K.; Mistry, P.; Raynaud, F. I.; Harrap, K. R.; Murrer, B. A.; Barnard, C. F. J. J. Pharm. Biomed. Anal. 1995, 13, 1493-1498.
70. (b) Pendyala, L.; Krishnan, B. S.; Walsh, J. R.; Arakali, A. V.; Cowens, J. W.; Creaven, P. J. Cancer Chemother. Pharmacol. 1989, 25, 10-14.
71. (a) Chen, Y.; Guo, Z.; Murdoch, P. del S.; Zang, E.; Sadler, P. J. J. Chem. Soc., Dalton Trans. 1998, 1503-1508.
72. (b) Siebert, A. F. M.; Sheldrick, W. S. J. Chem. Soc., Dalton Trans. 1997, 385-393.
73. (c) Guo, Z.; Hambley, T. W.; Murdoch, P. del S.; Sadler, P. J.; Frey, U. J. Chem. Soc., Dalton Trans. 1997, 469-478.
74. (d) Murdoch, P. del S.; Ranford, J. D.; Sadler, P. J.; Berners-Price, S. J. Inorg. Chem. 1993, 32, 2249-2255.
75. 2]. The reaction temperature had to be lowered to 288 K, to allow detection of the starting material after mixing; the diiodo Pt(II) complex had already disappeared after 4 h.
76. (a) Goto, K.; Holler, M.; Okazaki, R. Chem. Commun. 1998, 1915-1916.
77. (a) McBride, A. A.; Klausner, R. D.; Howley, P. M. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7531-535.
78. (b) Hegde, R. S.; Grossman, S. R.; Laimins, L. A.; Sigler, P. B. Nature 1992, 359, 505-512.
79. (c) Yeh, J. I.; Claiborne, A.; Hol, W. G. J. Biochemistry 1996, 35, 9951-9957.
80. (d) Stander, J. S.; Hausladen, A. Nat. Struct. Biol. 1998, 5, 247-249.
81. (e) Becker, K.; Savvides, S. N.; Keese, M.; Schirmer, R. H.; Karplus, P. A. Nat. Struct. Biol. 1998, 5, 267-271.
82. (f) Choi, H.-J.; Kang, S. W.; Yang, C.-H.; Rhee, S. G.; Ryu, S.-E. Nat. Struct. Biol. 1998, 5, 400-406.
83. (g) Bandyopadhyay, S.; Gronostajski, R. M. J. Biol. Chem. 1994, 209, 29949-29955.
84. (h) Abate, C.; Patel, L.; Rauscher, F. J., III; Curran, T. Science 1990, 249, 1157-1161.
85. (i) Zheng, M.; Åslund, F.; Storz, G. Science 1998, 279, 1718-1721.
86. (j) Allison, W. S. Acc. Chem. Res. 1976, 9, 293-299.
87. (k) Benitez, L. V.; Allison, W. S. J. Biol. Chem. 1974, 249, 6234-6243.
88. Some previous work on reductive elimination mechanisms has suggested the involvement of 5-coordinate transition states: (a) Goldberg, K. I.; Yan J.; Breitung, E. M. J. Am. Chem. Soc. 1995, 117, 6889-6896. (b) van Beek, J. A. M.; van Koten, G.; Smeets, W. J. J.; Spek, A. L. J. Am. Chem. Soc. 1986, 108, 5010-5011. (c) Byers, P. K.; Canty, A. J.; Crespo, M.; Puddephatt, R. J.; Scott, J. D. Organometalics 1988, 7, 1363-1367. However, a concerted mechanism giving rise directly to the ring-opened Pt(II) species is also possible. This amounts to the elimination of the attacked iodo ligand and the trans-amino group of ethylenediamine (the trans axis being defined by the ligand that is attacked by the reducing agent).
89. Some previous work on reductive elimination mechanisms has suggested the involvement of 5-coordinate transition states: (a) Goldberg, K. I.; Yan J.; Breitung, E. M. J. Am. Chem. Soc. 1995, 117, 6889-6896. (b) van Beek, J. A. M.; van Koten, G.; Smeets, W. J. J.; Spek, A. L. J. Am. Chem. Soc. 1986, 108, 5010-5011. (c) Byers, P. K.; Canty, A. J.; Crespo, M.; Puddephatt, R. J.; Scott, J. D. Organometalics 1988, 7, 1363-1367. However, a concerted mechanism giving rise directly to the ring-opened Pt(II) species is also possible. This amounts to the elimination of the attacked iodo ligand and the trans-amino group of ethylenediamine (the trans axis being defined by the ligand that is attacked by the reducing agent).
90. Some previous work on reductive elimination mechanisms has suggested the involvement of 5-coordinate transition states: (a) Goldberg, K. I.; Yan J.; Breitung, E. M. J. Am. Chem. Soc. 1995, 117, 6889-6896. (b) van Beek, J. A. M.; van Koten, G.; Smeets, W. J. J.; Spek, A. L. J. Am. Chem. Soc. 1986, 108, 5010-5011. (c) Byers, P. K.; Canty, A. J.; Crespo, M.; Puddephatt, R. J.; Scott, J. D. Organometalics 1988, 7, 1363-1367. However, a concerted mechanism giving rise directly to the ring-opened Pt(II) species is also possible. This amounts to the elimination of the attacked iodo ligand and the trans-amino group of ethylenediamine (the trans axis being defined by the ligand that is attacked by the reducing agent).
91. There is precedent for the reduction of disulfide bonds by Pt(II): (a) Lempers, E. L. M.; Inagaki, K.; Reedijk, J. Inorg. Chim. Acta 1980, 152, 201-207. (b) Ohta, N.; Inagaki, K.; Muta, H.; Yotsuyanagi, T.; Matsuo, T. Int. J. Pharmaceutics 1998, 161, 15-21. (c) Murdoch, P. del S.; Kratochwil, N. A.; Parkinson, J. A.; Patriarca, M.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, in press.
92. There is precedent for the reduction of disulfide bonds by Pt(II): (a) Lempers, E. L. M.; Inagaki, K.; Reedijk, J. Inorg. Chim. Acta 1980, 152, 201-207. (b) Ohta, N.; Inagaki, K.; Muta, H.; Yotsuyanagi, T.; Matsuo, T. Int. J. Pharmaceutics 1998, 161, 15-21. (c) Murdoch, P. del S.; Kratochwil, N. A.; Parkinson, J. A.; Patriarca, M.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, in press.
93. There is precedent for the reduction of disulfide bonds by Pt(II): (a) Lempers, E. L. M.; Inagaki, K.; Reedijk, J. Inorg. Chim. Acta 1980, 152, 201-207. (b) Ohta, N.; Inagaki, K.; Muta, H.; Yotsuyanagi, T.; Matsuo, T. Int. J. Pharmaceutics 1998, 161, 15-21. (c) Murdoch, P. del S.; Kratochwil, N. A.; Parkinson, J. A.; Patriarca, M.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, in press.
94. Appleton, T. G. Coord. Chem. Rev. 1997, 166, 313-359.
95. -.
96. Dhubhghaill, O. M. N.; Sadler, P. J. Struct. Bonding 1991, 78, 129-190.